AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on

AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab

AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Japan , Marc Dunoyer , Hubert Schrezenmeier , Committee For Medicinal Products Human , University Of Ulm , Drug Administration , European Medicines Agency , European Union , European Commission , Institute Of Transfusion Medicine , Medicinal Products , Human Use , Lancet Haematology , Medical Director , Transfusion Medicine , Chief Executive Officer , Functional Assessment , Chronic Illness Therapy , Breakthrough Therapy , Orphan Drug Designation ,